The BioCentury Report on Immuno-Oncology Industry Trends
PharmaTalkRadio
English - November 28, 2018 19:30 - 23 minutes - 20.5 MB - ★★★★ - 16 ratingsScience pharmaceutical biotech clinical trials patient engagement immuno-oncology drug delivery r&d Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: 5th Annual Immuno-Oncology 360˚: 12 minutes of What to Expect
Next Episode: Balancing Benefit and Toxicity from Immunotherapeutics
The BioCentury Report on Industry Trends covers how companies and academic investigators are driving innovations within immuno-oncology, including new targets, modalities and technologies, to address some of the field's biggest challenges. Some topics include:
The broadening trend to harness the innate and adaptive arms of the immune system for immunotherapiesNew cell types beyond CAR-T and traditional T-cellsCombination strategies for neoantigens and other targets from the earliest stages of drug development
This presentation, presented by Simone Fishburn, PhD, Editor, BioCentury Innovations, was given at the 4th Annual Immuno-Oncology 360° Event on February 7-9, 2018 in New York City.
Find more information at io360summit.com